Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAPATINIB Cause Pulmonary embolism? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Pulmonary embolism have been filed in association with LAPATINIB. This represents 1.3% of all adverse event reports for LAPATINIB.

26
Reports of Pulmonary embolism with LAPATINIB
1.3%
of all LAPATINIB reports
11
Deaths
20
Hospitalizations

How Dangerous Is Pulmonary embolism From LAPATINIB?

Of the 26 reports, 11 (42.3%) resulted in death, 20 (76.9%) required hospitalization, and 1 (3.8%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAPATINIB. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does LAPATINIB Cause?

Diarrhoea (382) Disease progression (227) Palmar-plantar erythrodysaesthesia syndrome (182) Malignant neoplasm progression (173) Nausea (161) Metastases to central nervous system (160) Neutropenia (160) Vomiting (155) Asthenia (148) Fatigue (139)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which LAPATINIB Alternatives Have Lower Pulmonary embolism Risk?

LAPATINIB vs LAPATINIB DITOSYLATE LAPATINIB vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN LAPATINIB vs LARONIDASE LAPATINIB vs LAROTRECTINIB LAPATINIB vs LASILIX

Related Pages

LAPATINIB Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism LAPATINIB Demographics